Rare case scenario when you’ll see so HUGE number of “securities class actions” and “class lawsuits” filings from well-known law firms against micro-cap company. Still curious what are reasons for? Let’s look at latest AMRS activities… In press-release from April 18th 2019 Amyris announced that company assigned right to Vitamin E royalties to DSM in […]
ADMA Biologics, Inc. (ADMA) shares price almost doubled since company announced that the FDA approved its Asceniv, intravenous immunoglobulin product for the treatment of primary humoral immunodeficiency disease (PIDD), in adults and adolescents ages from 12 to 17. PIDD is a collective term for numerous diseases that occur due to defects in the body’s immune […]
Shares of Proteostasis Therapeutics Inc. (PTI) slightly recovered during today’s trading after huge drop on Monday’s session when company announced results from a phase 1 study of its cystic fibrosis (CF) treatment. BOSTON, March 25, 2019 /PRNewswire/ — Proteostasis Therapeutics, Inc. (PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking […]
Histogenics Corp (NASDAQ: HSGX) shares were down 73% of their market value at time of publishing following the release data of its Phase 3 clinical trial of NeoCart that did not meet the primary endpoint of a statistically significant improvement in pain and function in a dual threshold responder analysis one year after treatment as […]
On June 26, 2018 Quantum Corp. (QTM) announced that its Board of Directors has appointed Jamie Lerner as Chief Executive Officer and President effective July 1, 2018. Lerner will also be appointed to Quantum’s Board of Directors. Lerner, a seasoned executive with experience developing innovative technology portfolios and leading high-growth organizations, will oversee the day-to-day […]
To be 100% correct in FCEL’s case – a chart is worth a thousand words. Pinch! Latest news from FCEL: FuelCell Energy Announces the Award of Two Fuel Cell Projects Totaling 22.2 Megawatts by Connecticut Department of Energy & Environmental Protection Jun 14, 2018 DANBURY, Conn., June 14, 2018 (GLOBE NEWSWIRE) — FuelCell Energy, Inc. […]
Investors have poured over $5.5 Million into a little known oil & gas name that is slowly making the rounds on Wall Street. They’re betting this company strikes oil in one of their many properties and becomes Exxon’s next takeout target. Who are we talking about? Read on… US Oil Production Will Hit […]
Curis, Inc. (NASDAQ: CRIS) – brief chart analysis for you – lots of room to grow Play on your own risk. About Curis, Inc. Curis, Inc., (NASDAQ: CRIS) a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. The company develops CUDC-907, […]
Chart/Volume Play – be sure that you read Curis’s PR beforehands: Curis, Inc. (CRIS), a biotechnology company, announced on September 14th, 2014 the pricing of an underwritten public offering of 20,000,000 shares of its common stock (the “Offering”). The Offering is expected to close on or about September 18, 2017, subject to customary closing conditions. […]
Trading opportunity – RTTR– don’t miss it. As usual – risky hence play it with guts. Shares Outstanding 11.62M Float 7.5M % Held by Insiders 30.71% % Held by Institutions 25.80% Shares Short 564920 (source – yahoo finance) Ritter Pharmaceuticals Announces Lactose Intolerance Treatment, RP-G28, Demonstrated Efficacy and Clinically Meaningful Benefit in Phase 2b/3 Clinical […]
